From: High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08
Country
Lead Ethical committee
Austria
Ethikkommission der Medizinischen Universität Innsbruck (AM4161b_LEK)
France
Comité de Protection des Personnes EST I (2011–52)
Switzerland
Ethikkommission Ostschweiz (EKSG 10/029)